Diabetic Ketoacidosis Severity (ADA)
ورودیهای بالینی بیمار
حداقل ۶.۸ — حداکثر ۷.۶
حداقل ۱ — حداکثر ۴۰ • واحد: mEq/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- classified≥ 0
The Diabetic Ketoacidosis Severity (ADA) calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include ph. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
ADA DKA severity classification.
Clinical Indication
The Diabetic Ketoacidosis Severity (ADA) is indicated for bedside clinical practice to support ADA DKA severity classification.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Worst of pH / bicarbonate / mental status axes determines severity
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| ph | float | Yes | Arterial/venous pH |
| bicarbonate | float | Yes | Serum bicarbonate(mEq/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | classified | DKA severity |
Evidence-Based References (EBM)
- Kitabchi AE, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343 (ADA consensus).